Mastek Partners With Innovaccer to Expand AI Healthcare Services; Shares Rise

Mumbai, August 3: Mastek Ltd. has entered into a strategic partnership with US-based healthcare technology company Innovaccer, strengthening its presence in the rapidly growing market for AI-powered healthcare solutions.

The collaboration will be executed through Mastek Inc., the company’s wholly owned step-down subsidiary. Under the partnership, Mastek will become Innovaccer’s Platinum Partner, enabling it to implement and scale the company’s healthcare intelligence platform, Gravity, for hospitals, healthcare providers and payers across North America, the UK, Europe and the Middle East.

Rather than being a conventional technology tie-up, the partnership combines two complementary strengths. Innovaccer brings its AI-native healthcare platform, which unifies fragmented clinical, operational and claims data, while Mastek contributes its expertise in digital engineering, cloud transformation, data platforms and enterprise AI implementation.

The companies said the objective is to help healthcare organisations convert large volumes of disconnected healthcare data into actionable insights, streamline operations, improve patient outcomes and reduce the overall cost of care.

The partnership also deepens Mastek’s footprint in healthcare, one of its key verticals, at a time when hospitals and health systems are increasingly investing in AI-led automation and data-driven decision-making.

Commenting on the development, Mastek said the alliance aligns with its long-term strategy of becoming a leading AI transformation partner for healthcare enterprises. Innovaccer, meanwhile, said Mastek’s global delivery capabilities and deep healthcare expertise would help accelerate adoption of its platform across strategic markets.

Mastek Share Price Trades Higher

Investors reacted positively to the announcement.

Mastek Share Price ends higher. Investors reacted positively to the announcement. On August 3, 2026, Mastek share price ended at ₹1,893.20, up ₹18.40, or 0.98%, on the NSE

While the partnership is not accompanied by a disclosed financial value, the market viewed it as a strategic step that could strengthen Mastek’s position in the fast-expanding healthcare AI ecosystem, an area expected to attract rising technology spending globally.

Company Background

Mastek is a global provider of digital engineering, cloud, data and AI services, serving clients across healthcare, financial services, government, manufacturing and retail. The company operates in more than 40 countries and works with technology partners including Microsoft, Oracle, Salesforce, AWS and Google Cloud.

Healthcare has become one of Mastek’s focus sectors, with the company increasingly investing in AI-led transformation, data modernisation and cloud-based enterprise solutions.

Conclusion

The Innovaccer partnership adds another strategic layer to Mastek’s AI ambitions rather than delivering an immediate revenue boost. By combining Mastek’s implementation capabilities with Innovaccer’s healthcare platform, the two companies aim to address growing demand for AI-enabled digital transformation across healthcare systems worldwide.

For investors, the key monitorable will be whether the partnership translates into large implementation projects and recurring enterprise engagements over the coming quarters, as healthcare organisations continue to accelerate AI adoption.

Source:

• https://www.nseindia.com/get-quote/equity/MASTEK/Mastek-Limited
• https://nsearchives.nseindia.com/corporate/MASTEK12_03082026152820_PressRelease03082026.pdf